ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1792

Participation in Psoriatic Arthritis (PART2) – a Cross-sectional Study of Work Impairment in Psoriatic Arthritis Patients in the Netherlands

Tamara van Hal1, Michelle Mulder1, Mark Wenink2 and Johanna Vriezekolk1, 1Sint Maartenskliniek, Nijmegen, Netherlands, 2Sint Maartenskliniek, Malden, Netherlands

Meeting: ACR Convergence 2021

Keywords: Psoriatic arthritis, work

  • Tweet
  • Email
  • Print
Session Information

Date: Tuesday, November 9, 2021

Title: Spondyloarthritis Including PsA – Diagnosis, Manifestations, & Outcomes Poster IV: Clinical Aspects of PsA & Peripheral SpA (1773–1800)

Session Type: Poster Session D

Session Time: 8:30AM-10:30AM

Background/Purpose: Psoriatic arthritis (PsA) can lead to pain, disability and a loss of quality of life [Rosen, Rheumatology 2012]. PsA can also lead to impairments in work and social activities, increasing societal costs. The magnitude and determinants of these impairments in Dutch PsA patients is insufficiently researched.

Methods: This cross-sectional study used sociodemographic and clinical data collected from the electronic patient files of PsA patients treated at the department of rheumatology of the Sint Maartenskliniek, Netherlands. All patients were treated according to Psoriatic Arthritis Disease Activity Score (PASDAS) driven treat-to-target, as described previously [Mulder, Rheumatology 2020]. Data about work and activity impairment were collected via the Work Productivity and Activity Impairment (WPAI) questionnaire. To compare our PsA-cohort with the Dutch general population (GP), we used age- and sex-matched data derived from the Central Bureau of Statistics. Regression analyses were performed to examine determinants of impairment.

Results: 246 patients were included in this study, of which 125 (48.8%) were male. Mean age was 55.7 years (SD=13.2). Over half of the patients had a paid job (work-for-pay, WFP, 53%). Compared to the age-and sex-matched Dutch GP, less patients with PsA had a paid job (Dutch GP 63% vs. PsA cohort 53%, p < 0.001). A lower age and a better physical function (Health Assessment Questionnaire-Disability Index (HAQ-DI)) were associated with WFP-status. Overall work impairment of those with a paid job was 10% (interquartile range, 10-40%). In this subgroup, higher disease activity score (PASDAS), worse physical function (HAQ-DI) and worse mental health-related quality of life (Mental Component Summary score – MCS-12) were associated with more work impairment (p< =0.05). Notably, age, sex and treatment modality were not associated with work impairment.

Conclusion: Our study indicates that Dutch patients with PsA were less likely to have a paid job compared to the Dutch general population. When working, they suffered an average productivity loss of 10%. Physical function seems to be a shared factor in the risk for work impairment as well as the risk for not having a paid job. Lower disease activity as measured by PASDAS seems to protect against work impairment, regardless of treatment modality. We suggest that by maintaining adequate disease control, patients can be protected from work impairment and future inability to work or loss of job.


Disclosures: T. van Hal, Novartis, 6, UCB, 6, 12, paid congress visit, Eli Lily, 6; M. Mulder, None; M. Wenink, None; J. Vriezekolk, None.

To cite this abstract in AMA style:

van Hal T, Mulder M, Wenink M, Vriezekolk J. Participation in Psoriatic Arthritis (PART2) – a Cross-sectional Study of Work Impairment in Psoriatic Arthritis Patients in the Netherlands [abstract]. Arthritis Rheumatol. 2021; 73 (suppl 9). https://acrabstracts.org/abstract/participation-in-psoriatic-arthritis-part2-a-cross-sectional-study-of-work-impairment-in-psoriatic-arthritis-patients-in-the-netherlands/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2021

ACR Meeting Abstracts - https://acrabstracts.org/abstract/participation-in-psoriatic-arthritis-part2-a-cross-sectional-study-of-work-impairment-in-psoriatic-arthritis-patients-in-the-netherlands/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology